Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation
ObjectiveChronic obstructive pulmonary disease (COPD) is associated with the development of atrial fibrillation (AF), and may complicate treatment of AF. We examined the association between COPD and symptoms, quality of life (QoL), treatment and outcomes among patients with AF.MethodsWe compared pat...
Gespeichert in:
Veröffentlicht in: | Heart (British Cardiac Society) 2018-11, Vol.104 (22), p.1850-1858 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1858 |
---|---|
container_issue | 22 |
container_start_page | 1850 |
container_title | Heart (British Cardiac Society) |
container_volume | 104 |
creator | Durheim, Michael T Holmes, DaJuanicia N Blanco, Rosalia G Allen, Larry A Chan, Paul S Freeman, James V Fonarow, Gregg C Go, Alan S Hylek, Elaine M Mahaffey, Kenneth W Pokorney, Sean D Reiffel, James A Singer, Daniel E Peterson, Eric D Piccini, Jonathan P |
description | ObjectiveChronic obstructive pulmonary disease (COPD) is associated with the development of atrial fibrillation (AF), and may complicate treatment of AF. We examined the association between COPD and symptoms, quality of life (QoL), treatment and outcomes among patients with AF.MethodsWe compared patients with and without a diagnosis of COPD in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation, a prospective registry that enrolled outpatients with AF not secondary to reversible causes, from both academic and community settings.ResultsAmong 9749 patients with AF, 1605 (16%) had COPD. Relative to patients without COPD, those with COPD were more likely to be older, current/former smokers (73% vs 43%), have heart failure (54% vs 29%) and coronary artery disease (49% vs 34%). Oral anticoagulant and beta blocker use were similar, whereas digoxin use was more common among patients with COPD. Symptom burden was generally higher, and QoL worse, among patients with COPD (median Atrial Fibrillation Effect on QualiTy-of-Life score 76 vs 83). Patients with COPD had higher risk of all-cause mortality (adjusted HR 1.52 (95% CI 1.32 to 1.74)), cardiovascular mortality (adjusted HR 1.51 (95% CI 1.24 to 1.84)) and cardiovascular hospitalisation (adjusted HR 1.15 (95% CI 1.05 to 1.26)). Patients with COPD also had higher risk of major bleeding events (adjusted HR 1.25 (95% CI 1.05 to 1.50)). There did not appear to be associations between COPD and AF progression, ischaemic events or new-onset heart failure.ConclusionsAmong patients with AF, COPD is associated with higher symptom burden, worse QoL, and worse cardiovascular and bleeding outcomes. These associations were not fully explained by cardiovascular risk factors, AF treatment or smoking history.Clinical registration numberNCT01165710 |
doi_str_mv | 10.1136/heartjnl-2017-312735 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2051660061</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2051660061</sourcerecordid><originalsourceid>FETCH-LOGICAL-b375t-3fa1fedf1e03f1f5bf4e3be05f9d88889fdff2d2328987ff6214f66520deef033</originalsourceid><addsrcrecordid>eNqNkU1r3DAQhkVJ6Oaj_6AUQS69uKsPS7aPZUnbQCCXBHITsjXDarGtrSSn5N9H201y6KlzmWF45mVmXkI-c_aNc6nXW7Ax7-axEow3leSikeoDOeO1bg-tx5NSS6UqzWSzIucp7Rhjddfqj2QlurZRXHZnxG-2NtohQ_Qp-yFROzsaljyECRINSK1bxpzoH5-3dNjGMPuBhj7luAzZPwHdL-MUZhufqfMJbIK_CjZHb0eKvo9-HG32Yb4kp2jHBJ9e8wV5-HF9v_lV3d79vNl8v6162ahcSbQcwSEHJpGj6rEG2QNT2Lm2RIcOUTghRVuOQNSC16i1EswBIJPygnw96u5j-L1AymbyaYCyxQxhSUYwxbVmTPOCXv2D7sIS57KdEVy0SjblX4Wqj9QQQ0oR0Oyjn8rFhjNzsMK8WWEOVpijFWXsy6v40k_g3ofefl-A9RHop93_Sb4AsSyYkQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2128537498</pqid></control><display><type>article</type><title>Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation</title><source>MEDLINE</source><source>PubMed Central</source><creator>Durheim, Michael T ; Holmes, DaJuanicia N ; Blanco, Rosalia G ; Allen, Larry A ; Chan, Paul S ; Freeman, James V ; Fonarow, Gregg C ; Go, Alan S ; Hylek, Elaine M ; Mahaffey, Kenneth W ; Pokorney, Sean D ; Reiffel, James A ; Singer, Daniel E ; Peterson, Eric D ; Piccini, Jonathan P</creator><creatorcontrib>Durheim, Michael T ; Holmes, DaJuanicia N ; Blanco, Rosalia G ; Allen, Larry A ; Chan, Paul S ; Freeman, James V ; Fonarow, Gregg C ; Go, Alan S ; Hylek, Elaine M ; Mahaffey, Kenneth W ; Pokorney, Sean D ; Reiffel, James A ; Singer, Daniel E ; Peterson, Eric D ; Piccini, Jonathan P</creatorcontrib><description>ObjectiveChronic obstructive pulmonary disease (COPD) is associated with the development of atrial fibrillation (AF), and may complicate treatment of AF. We examined the association between COPD and symptoms, quality of life (QoL), treatment and outcomes among patients with AF.MethodsWe compared patients with and without a diagnosis of COPD in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation, a prospective registry that enrolled outpatients with AF not secondary to reversible causes, from both academic and community settings.ResultsAmong 9749 patients with AF, 1605 (16%) had COPD. Relative to patients without COPD, those with COPD were more likely to be older, current/former smokers (73% vs 43%), have heart failure (54% vs 29%) and coronary artery disease (49% vs 34%). Oral anticoagulant and beta blocker use were similar, whereas digoxin use was more common among patients with COPD. Symptom burden was generally higher, and QoL worse, among patients with COPD (median Atrial Fibrillation Effect on QualiTy-of-Life score 76 vs 83). Patients with COPD had higher risk of all-cause mortality (adjusted HR 1.52 (95% CI 1.32 to 1.74)), cardiovascular mortality (adjusted HR 1.51 (95% CI 1.24 to 1.84)) and cardiovascular hospitalisation (adjusted HR 1.15 (95% CI 1.05 to 1.26)). Patients with COPD also had higher risk of major bleeding events (adjusted HR 1.25 (95% CI 1.05 to 1.50)). There did not appear to be associations between COPD and AF progression, ischaemic events or new-onset heart failure.ConclusionsAmong patients with AF, COPD is associated with higher symptom burden, worse QoL, and worse cardiovascular and bleeding outcomes. These associations were not fully explained by cardiovascular risk factors, AF treatment or smoking history.Clinical registration numberNCT01165710</description><identifier>ISSN: 1355-6037</identifier><identifier>EISSN: 1468-201X</identifier><identifier>DOI: 10.1136/heartjnl-2017-312735</identifier><identifier>PMID: 29875139</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Aged ; Aged, 80 and over ; Anti-Arrhythmia Agents - adverse effects ; Anticoagulants ; Anticoagulants - adverse effects ; Atrial Fibrillation - epidemiology ; Atrial Fibrillation - mortality ; Atrial Fibrillation - physiopathology ; Atrial Fibrillation - therapy ; Beta blockers ; Chronic obstructive pulmonary disease ; Comorbidity ; Female ; Health Status ; Heart Conduction System - drug effects ; Heart Conduction System - physiopathology ; Hemorrhage - chemically induced ; Hospitalization ; Humans ; Lung - physiopathology ; Male ; Mortality ; Prevalence ; Pulmonary Disease, Chronic Obstructive - epidemiology ; Pulmonary Disease, Chronic Obstructive - mortality ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Pulmonary Disease, Chronic Obstructive - therapy ; Quality of Life ; Registries ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; United States - epidemiology</subject><ispartof>Heart (British Cardiac Society), 2018-11, Vol.104 (22), p.1850-1858</ispartof><rights>Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><rights>2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b375t-3fa1fedf1e03f1f5bf4e3be05f9d88889fdff2d2328987ff6214f66520deef033</citedby><cites>FETCH-LOGICAL-b375t-3fa1fedf1e03f1f5bf4e3be05f9d88889fdff2d2328987ff6214f66520deef033</cites><orcidid>0000-0002-4186-5698</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29875139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Durheim, Michael T</creatorcontrib><creatorcontrib>Holmes, DaJuanicia N</creatorcontrib><creatorcontrib>Blanco, Rosalia G</creatorcontrib><creatorcontrib>Allen, Larry A</creatorcontrib><creatorcontrib>Chan, Paul S</creatorcontrib><creatorcontrib>Freeman, James V</creatorcontrib><creatorcontrib>Fonarow, Gregg C</creatorcontrib><creatorcontrib>Go, Alan S</creatorcontrib><creatorcontrib>Hylek, Elaine M</creatorcontrib><creatorcontrib>Mahaffey, Kenneth W</creatorcontrib><creatorcontrib>Pokorney, Sean D</creatorcontrib><creatorcontrib>Reiffel, James A</creatorcontrib><creatorcontrib>Singer, Daniel E</creatorcontrib><creatorcontrib>Peterson, Eric D</creatorcontrib><creatorcontrib>Piccini, Jonathan P</creatorcontrib><title>Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation</title><title>Heart (British Cardiac Society)</title><addtitle>Heart</addtitle><description>ObjectiveChronic obstructive pulmonary disease (COPD) is associated with the development of atrial fibrillation (AF), and may complicate treatment of AF. We examined the association between COPD and symptoms, quality of life (QoL), treatment and outcomes among patients with AF.MethodsWe compared patients with and without a diagnosis of COPD in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation, a prospective registry that enrolled outpatients with AF not secondary to reversible causes, from both academic and community settings.ResultsAmong 9749 patients with AF, 1605 (16%) had COPD. Relative to patients without COPD, those with COPD were more likely to be older, current/former smokers (73% vs 43%), have heart failure (54% vs 29%) and coronary artery disease (49% vs 34%). Oral anticoagulant and beta blocker use were similar, whereas digoxin use was more common among patients with COPD. Symptom burden was generally higher, and QoL worse, among patients with COPD (median Atrial Fibrillation Effect on QualiTy-of-Life score 76 vs 83). Patients with COPD had higher risk of all-cause mortality (adjusted HR 1.52 (95% CI 1.32 to 1.74)), cardiovascular mortality (adjusted HR 1.51 (95% CI 1.24 to 1.84)) and cardiovascular hospitalisation (adjusted HR 1.15 (95% CI 1.05 to 1.26)). Patients with COPD also had higher risk of major bleeding events (adjusted HR 1.25 (95% CI 1.05 to 1.50)). There did not appear to be associations between COPD and AF progression, ischaemic events or new-onset heart failure.ConclusionsAmong patients with AF, COPD is associated with higher symptom burden, worse QoL, and worse cardiovascular and bleeding outcomes. These associations were not fully explained by cardiovascular risk factors, AF treatment or smoking history.Clinical registration numberNCT01165710</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Arrhythmia Agents - adverse effects</subject><subject>Anticoagulants</subject><subject>Anticoagulants - adverse effects</subject><subject>Atrial Fibrillation - epidemiology</subject><subject>Atrial Fibrillation - mortality</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Atrial Fibrillation - therapy</subject><subject>Beta blockers</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Comorbidity</subject><subject>Female</subject><subject>Health Status</subject><subject>Heart Conduction System - drug effects</subject><subject>Heart Conduction System - physiopathology</subject><subject>Hemorrhage - chemically induced</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Lung - physiopathology</subject><subject>Male</subject><subject>Mortality</subject><subject>Prevalence</subject><subject>Pulmonary Disease, Chronic Obstructive - epidemiology</subject><subject>Pulmonary Disease, Chronic Obstructive - mortality</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Pulmonary Disease, Chronic Obstructive - therapy</subject><subject>Quality of Life</subject><subject>Registries</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>United States - epidemiology</subject><issn>1355-6037</issn><issn>1468-201X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkU1r3DAQhkVJ6Oaj_6AUQS69uKsPS7aPZUnbQCCXBHITsjXDarGtrSSn5N9H201y6KlzmWF45mVmXkI-c_aNc6nXW7Ax7-axEow3leSikeoDOeO1bg-tx5NSS6UqzWSzIucp7Rhjddfqj2QlurZRXHZnxG-2NtohQ_Qp-yFROzsaljyECRINSK1bxpzoH5-3dNjGMPuBhj7luAzZPwHdL-MUZhufqfMJbIK_CjZHb0eKvo9-HG32Yb4kp2jHBJ9e8wV5-HF9v_lV3d79vNl8v6162ahcSbQcwSEHJpGj6rEG2QNT2Lm2RIcOUTghRVuOQNSC16i1EswBIJPygnw96u5j-L1AymbyaYCyxQxhSUYwxbVmTPOCXv2D7sIS57KdEVy0SjblX4Wqj9QQQ0oR0Oyjn8rFhjNzsMK8WWEOVpijFWXsy6v40k_g3ofefl-A9RHop93_Sb4AsSyYkQ</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Durheim, Michael T</creator><creator>Holmes, DaJuanicia N</creator><creator>Blanco, Rosalia G</creator><creator>Allen, Larry A</creator><creator>Chan, Paul S</creator><creator>Freeman, James V</creator><creator>Fonarow, Gregg C</creator><creator>Go, Alan S</creator><creator>Hylek, Elaine M</creator><creator>Mahaffey, Kenneth W</creator><creator>Pokorney, Sean D</creator><creator>Reiffel, James A</creator><creator>Singer, Daniel E</creator><creator>Peterson, Eric D</creator><creator>Piccini, Jonathan P</creator><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4186-5698</orcidid></search><sort><creationdate>201811</creationdate><title>Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation</title><author>Durheim, Michael T ; Holmes, DaJuanicia N ; Blanco, Rosalia G ; Allen, Larry A ; Chan, Paul S ; Freeman, James V ; Fonarow, Gregg C ; Go, Alan S ; Hylek, Elaine M ; Mahaffey, Kenneth W ; Pokorney, Sean D ; Reiffel, James A ; Singer, Daniel E ; Peterson, Eric D ; Piccini, Jonathan P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b375t-3fa1fedf1e03f1f5bf4e3be05f9d88889fdff2d2328987ff6214f66520deef033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Arrhythmia Agents - adverse effects</topic><topic>Anticoagulants</topic><topic>Anticoagulants - adverse effects</topic><topic>Atrial Fibrillation - epidemiology</topic><topic>Atrial Fibrillation - mortality</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Atrial Fibrillation - therapy</topic><topic>Beta blockers</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Comorbidity</topic><topic>Female</topic><topic>Health Status</topic><topic>Heart Conduction System - drug effects</topic><topic>Heart Conduction System - physiopathology</topic><topic>Hemorrhage - chemically induced</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Lung - physiopathology</topic><topic>Male</topic><topic>Mortality</topic><topic>Prevalence</topic><topic>Pulmonary Disease, Chronic Obstructive - epidemiology</topic><topic>Pulmonary Disease, Chronic Obstructive - mortality</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Pulmonary Disease, Chronic Obstructive - therapy</topic><topic>Quality of Life</topic><topic>Registries</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Durheim, Michael T</creatorcontrib><creatorcontrib>Holmes, DaJuanicia N</creatorcontrib><creatorcontrib>Blanco, Rosalia G</creatorcontrib><creatorcontrib>Allen, Larry A</creatorcontrib><creatorcontrib>Chan, Paul S</creatorcontrib><creatorcontrib>Freeman, James V</creatorcontrib><creatorcontrib>Fonarow, Gregg C</creatorcontrib><creatorcontrib>Go, Alan S</creatorcontrib><creatorcontrib>Hylek, Elaine M</creatorcontrib><creatorcontrib>Mahaffey, Kenneth W</creatorcontrib><creatorcontrib>Pokorney, Sean D</creatorcontrib><creatorcontrib>Reiffel, James A</creatorcontrib><creatorcontrib>Singer, Daniel E</creatorcontrib><creatorcontrib>Peterson, Eric D</creatorcontrib><creatorcontrib>Piccini, Jonathan P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Heart (British Cardiac Society)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Durheim, Michael T</au><au>Holmes, DaJuanicia N</au><au>Blanco, Rosalia G</au><au>Allen, Larry A</au><au>Chan, Paul S</au><au>Freeman, James V</au><au>Fonarow, Gregg C</au><au>Go, Alan S</au><au>Hylek, Elaine M</au><au>Mahaffey, Kenneth W</au><au>Pokorney, Sean D</au><au>Reiffel, James A</au><au>Singer, Daniel E</au><au>Peterson, Eric D</au><au>Piccini, Jonathan P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation</atitle><jtitle>Heart (British Cardiac Society)</jtitle><addtitle>Heart</addtitle><date>2018-11</date><risdate>2018</risdate><volume>104</volume><issue>22</issue><spage>1850</spage><epage>1858</epage><pages>1850-1858</pages><issn>1355-6037</issn><eissn>1468-201X</eissn><abstract>ObjectiveChronic obstructive pulmonary disease (COPD) is associated with the development of atrial fibrillation (AF), and may complicate treatment of AF. We examined the association between COPD and symptoms, quality of life (QoL), treatment and outcomes among patients with AF.MethodsWe compared patients with and without a diagnosis of COPD in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation, a prospective registry that enrolled outpatients with AF not secondary to reversible causes, from both academic and community settings.ResultsAmong 9749 patients with AF, 1605 (16%) had COPD. Relative to patients without COPD, those with COPD were more likely to be older, current/former smokers (73% vs 43%), have heart failure (54% vs 29%) and coronary artery disease (49% vs 34%). Oral anticoagulant and beta blocker use were similar, whereas digoxin use was more common among patients with COPD. Symptom burden was generally higher, and QoL worse, among patients with COPD (median Atrial Fibrillation Effect on QualiTy-of-Life score 76 vs 83). Patients with COPD had higher risk of all-cause mortality (adjusted HR 1.52 (95% CI 1.32 to 1.74)), cardiovascular mortality (adjusted HR 1.51 (95% CI 1.24 to 1.84)) and cardiovascular hospitalisation (adjusted HR 1.15 (95% CI 1.05 to 1.26)). Patients with COPD also had higher risk of major bleeding events (adjusted HR 1.25 (95% CI 1.05 to 1.50)). There did not appear to be associations between COPD and AF progression, ischaemic events or new-onset heart failure.ConclusionsAmong patients with AF, COPD is associated with higher symptom burden, worse QoL, and worse cardiovascular and bleeding outcomes. These associations were not fully explained by cardiovascular risk factors, AF treatment or smoking history.Clinical registration numberNCT01165710</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>29875139</pmid><doi>10.1136/heartjnl-2017-312735</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-4186-5698</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-6037 |
ispartof | Heart (British Cardiac Society), 2018-11, Vol.104 (22), p.1850-1858 |
issn | 1355-6037 1468-201X |
language | eng |
recordid | cdi_proquest_miscellaneous_2051660061 |
source | MEDLINE; PubMed Central |
subjects | Aged Aged, 80 and over Anti-Arrhythmia Agents - adverse effects Anticoagulants Anticoagulants - adverse effects Atrial Fibrillation - epidemiology Atrial Fibrillation - mortality Atrial Fibrillation - physiopathology Atrial Fibrillation - therapy Beta blockers Chronic obstructive pulmonary disease Comorbidity Female Health Status Heart Conduction System - drug effects Heart Conduction System - physiopathology Hemorrhage - chemically induced Hospitalization Humans Lung - physiopathology Male Mortality Prevalence Pulmonary Disease, Chronic Obstructive - epidemiology Pulmonary Disease, Chronic Obstructive - mortality Pulmonary Disease, Chronic Obstructive - physiopathology Pulmonary Disease, Chronic Obstructive - therapy Quality of Life Registries Risk Assessment Risk Factors Time Factors Treatment Outcome United States - epidemiology |
title | Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T23%3A12%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20and%20outcomes%20of%20adults%20with%20chronic%20obstructive%20pulmonary%20disease%20and%20atrial%20fibrillation&rft.jtitle=Heart%20(British%20Cardiac%20Society)&rft.au=Durheim,%20Michael%20T&rft.date=2018-11&rft.volume=104&rft.issue=22&rft.spage=1850&rft.epage=1858&rft.pages=1850-1858&rft.issn=1355-6037&rft.eissn=1468-201X&rft_id=info:doi/10.1136/heartjnl-2017-312735&rft_dat=%3Cproquest_cross%3E2051660061%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2128537498&rft_id=info:pmid/29875139&rfr_iscdi=true |